Qualigen Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
33.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.30
|
-1.00
|
0.30
|
23.08%
|
|
2022-06-30
|
-1.60
|
-1.10
|
0.50
|
31.25%
|
|
2022-03-31
|
-1.70
|
-2.00
|
-0.30
|
-17.65%
|
|
2021-12-31
|
-1.70
|
-2.00
|
-0.30
|
-17.65%
|
|
2021-09-30
|
-1.95
|
-1.00
|
0.95
|
48.72%
|
|
2021-06-30
|
-1.85
|
-1.80
|
0.05
|
2.70%
|
|
2021-03-31
|
-1.60
|
-1.30
|
0.30
|
18.75%
|
|
2020-12-31
|
-1.30
|
8.50
|
9.80
|
753.85%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.10
|
|
2021-12-31
|
-6.10
|
|
2020-12-31
|
4.76
|
|
2019-12-31
|
-28.95
|
|
2018-12-31
|
-91.00
|
|
2017-12-31
|
-5.30
|
|
2016-12-31
|
-19.90
|
|
2015-12-31
|
-1144.81
|